Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för David Shapiro. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att David Shapiro har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ONVO / Organovo Holdings, Inc. | Director | 52 000 |
US:ICPT / Intercept Pharmaceuticals Inc | Chief Medical Officer | 9 031 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av David Shapiro. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp VIVS / VivoSim Labs, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i VIVS / VivoSim Labs, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i VIVS / VivoSim Labs, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av David Shapiro som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-09-09 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 52 000 | 52 000 | |||||
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 9 031 | −18,13 | |||
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 499 | −4,82 | 86,28 | −172 560 | 3 407 974 |
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 499 | 5,06 | 31,90 | 63 800 | 1 323 818 |
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 11 031 | −15,35 | |||
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 499 | −4,82 | 95,00 | −190 000 | 3 752 405 |
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 499 | 5,06 | 31,90 | 63 800 | 1 323 818 |
2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −562 | 39 499 | −1,40 | 115,01 | −64 636 | 4 542 780 |
2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −482 | 40 061 | −1,19 | 111,50 | −53 743 | 4 466 802 | |
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 13 031 | −13,31 | |||
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 40 543 | −4,70 | 103,16 | −206 320 | 4 182 416 |
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 42 543 | 4,93 | 31,90 | 63 800 | 1 357 122 |
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 15 031 | −11,74 | |||
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 40 543 | −4,70 | 111,51 | −223 020 | 4 520 950 |
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 42 543 | 4,93 | 31,90 | 63 800 | 1 357 122 |
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 5 300 | 5 300 | |||||
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 300 | 40 543 | 8,86 | ||||
2019-01-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −474 | 37 243 | −1,26 | 97,48 | −46 206 | 3 630 448 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −699 | 37 717 | −1,82 | 97,45 | −68 118 | 3 675 522 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 17 031 | −10,51 | |||
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 38 416 | −4,95 | 98,28 | −196 560 | 3 775 524 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 40 416 | 5,21 | 31,90 | 63 800 | 1 289 270 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −736 | 38 416 | −1,88 | 100,79 | −74 181 | 3 871 949 | |
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 19 031 | −9,51 | |||
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 152 | −4,86 | 106,62 | −213 240 | 4 174 386 |
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 152 | 5,11 | 31,90 | 63 800 | 1 312 749 |
2018-12-06 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2018-12-06 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 46 500 | 46 500 | |||||
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 361 | −84,71 | |||
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 152 | −4,86 | 96,32 | −192 640 | 3 771 121 |
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 152 | 5,11 | 21,50 | 43 000 | 884 768 |
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −3 425 | 2 361 | −59,19 | |||
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 425 | 39 152 | −8,04 | 102,95 | −352 604 | 4 030 698 |
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 425 | 42 577 | 8,75 | 21,50 | 73 638 | 915 406 |
2018-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −759 | 39 152 | −1,90 | 110,65 | −83 983 | 4 332 169 |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −426 | 39 911 | −1,06 | 126,46 | −53 872 | 5 047 145 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −416 | 39 911 | −1,03 | 83,91 | −34 907 | 3 348 932 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −423 | 39 911 | −1,05 | 61,52 | −26 023 | 2 455 325 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 020 | 39 911 | −2,49 | 58,42 | −59 588 | 2 331 601 | |
2018-09-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 917 | 42 196 | −10,44 | 111,43 | −547 891 | 4 701 816 | |
2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 4 400 | 4 400 | |||||
2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 2 900 | 47 113 | 6,56 | ||||
2017-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −349 | 44 213 | −0,78 | 58,90 | −20 556 | 2 604 071 | |
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 250 | 21 031 | −5,61 | ||||
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 250 | 44 562 | −2,73 | 117,43 | −146 788 | 5 232 916 |
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 250 | 45 812 | 2,81 | 31,90 | 39 875 | 1 461 403 |
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 118 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 118 | 44 562 | −2,45 | 119,00 | −133 042 | 5 302 878 |
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 118 | 45 680 | 2,51 | 8,67 | 9 689 | 395 895 |
2017-07-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −553 | 44 562 | −1,23 | 124,01 | −68 578 | 5 526 134 |
2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −100 | 45 115 | −0,22 | 121,35 | −12 135 | 5 474 705 | |
2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −250 | 45 215 | −0,55 | 121,20 | −30 300 | 5 480 058 | |
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 117 | 1 118 | −49,98 | ||||
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 117 | 45 465 | −2,40 | 112,18 | −125 305 | 5 100 264 |
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 117 | 46 582 | 2,46 | 8,67 | 9 681 | 403 712 |
2017-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −558 | 45 465 | −1,21 | 108,51 | −60 549 | 4 933 407 |
2017-04-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −346 | 46 023 | −0,75 | 115,00 | −39 789 | 5 292 521 | |
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 350 | 5 786 | −18,92 | ||||
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 46 369 | −2,83 | 128,66 | −173 691 | 5 965 836 |
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 350 | 47 719 | 2,91 | 21,50 | 29 025 | 1 025 958 |
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 6 000 | 46 369 | 14,86 | ||||
2017-01-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 565 | 40 369 | −3,73 | 106,01 | −165 906 | 4 279 518 |
2017-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −988 | 41 934 | −2,30 | 103,92 | −102 672 | 4 357 744 | |
2016-12-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 42 922 | −3,05 | 99,75 | −134 662 | 4 281 470 |
2016-10-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −411 | 44 272 | −0,92 | 153,34 | −63 023 | 6 788 668 |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −1 350 | 8 486 | −13,73 | |||
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −163 | 44 683 | −0,36 | 163,20 | −26 602 | 7 292 252 | |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 44 846 | −2,92 | 163,06 | −220 131 | 7 312 589 |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 350 | 46 196 | 3,01 | 21,50 | 29 025 | 993 214 |
2016-09-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −886 | 44 846 | −1,94 | 166,03 | −147 103 | 7 445 781 |
2016-09-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 659 | 45 732 | −5,49 | 164,76 | −438 097 | 7 534 809 |
2016-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −163 | 48 391 | −0,34 | 145,11 | −23 653 | 7 021 979 | |
2016-04-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −165 | 48 546 | −0,34 | 130,76 | −21 575 | 6 347 875 | |
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 10 200 | 10 200 | |||||
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 7 800 | 48 711 | 19,07 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −496 | 40 911 | −1,20 | 145,90 | −72 368 | 5 969 066 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −37 | 41 407 | −0,09 | 145,90 | −5 398 | 6 041 435 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 0 | −100,00 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 41 444 | 4,08 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −219 | 22 281 | −0,97 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −7 471 | 9 836 | −43,17 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −3 736 | 2 235 | −62,57 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 219 | 39 821 | 0,55 | 31,90 | 6 986 | 1 270 290 | |
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 471 | 39 602 | 23,25 | 21,50 | 160 626 | 851 443 | |
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 736 | 32 131 | 13,16 | 8,67 | 32 379 | 278 470 | |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 28 395 | −3,40 | 157,45 | −157 450 | 4 470 793 |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 29 395 | −7,84 | 157,38 | −393 450 | 4 626 188 |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 31 895 | 12,33 | 8,67 | 30 333 | 276 424 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 3 500 | −50,00 | |||
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 28 395 | −5,02 | 179,49 | −269 235 | 5 096 619 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 764 | 29 895 | −8,46 | 178,00 | −492 002 | 5 321 421 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 32 659 | 12,00 | 8,67 | 30 333 | 283 046 |
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 7 000 | −33,33 | |||
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 500 | 29 159 | −10,72 | 204,15 | −714 525 | 5 952 810 |
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 32 659 | 12,00 | 8,67 | 30 333 | 283 046 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −858 | 29 159 | −2,86 | 159,04 | −136 456 | 4 637 427 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 622 | 1 623 | −49,98 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 13 100 | 13 100 | |||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −282 | 30 017 | −0,93 | 163,39 | −46 076 | 4 904 478 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 30 299 | 5,66 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 5 150 | 28 677 | 21,89 | ||||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 294 | 10 500 | −33,52 | |||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 15 794 | −18,14 | |||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 23 527 | −5,99 | 192,85 | −289 275 | 4 537 182 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 25 027 | −3,84 | 191,04 | −191 044 | 4 781 263 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 26 027 | −3,70 | 189,16 | −189 161 | 4 923 296 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 294 | 27 027 | 24,36 | 8,67 | 45 882 | 234 235 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 21 733 | 19,20 | 8,67 | 30 333 | 188 353 |
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 19 294 | −15,35 | |||
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 272 | 18 233 | −18,98 | 209,37 | −894 429 | 3 817 443 |
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 505 | 18,42 | 8,67 | 30 333 | 195 044 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 | 19 005 | −0,22 | 239,00 | −9 799 | 4 542 197 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 | 19 046 | −0,05 | 238,16 | −2 143 | 4 535 997 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −801 | 19 055 | −4,03 | 236,13 | −189 140 | 4 499 457 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 3 245 | −33,34 | ||||
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 19 856 | 8,90 | ||||
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 22 794 | −13,31 | |||
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 18 233 | −0,55 | 241,81 | −24 181 | 4 408 922 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −381 | 18 333 | −2,04 | 240,59 | −91 664 | 4 410 722 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −398 | 18 714 | −2,08 | 239,32 | −95 251 | 4 478 702 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 902 | 19 112 | −9,05 | 238,51 | −453 641 | 4 558 357 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 21 014 | −4,54 | 237,64 | −237 640 | 4 993 763 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 014 | 18,90 | 8,67 | 30 333 | 190 789 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 26 294 | −11,75 | |||
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 900 | 18 514 | −9,31 | 242,05 | −459 896 | 4 481 323 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 20 414 | −7,27 | 241,03 | −385 650 | 4 920 413 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 014 | 18,90 | 8,67 | 30 333 | 190 789 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 29 794 | −10,51 | |||
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 984 | 18 514 | −9,68 | 307,60 | −610 274 | 5 694 866 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 295 | 20 498 | −10,07 | 306,31 | −702 970 | 6 278 644 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 793 | 18,14 | 8,67 | 30 333 | 197 540 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −843 | 19 293 | −4,19 | 277,70 | −234 102 | 5 357 678 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −2 131 | 33 294 | −6,02 | |||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −203 | 0 | −100,00 | |||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 4 868 | −24,99 | ||||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 20 136 | −4,73 | 281,15 | −281 150 | 5 661 236 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −282 | 21 136 | −1,32 | 272,69 | −76 897 | 5 763 483 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 334 | 21 418 | −5,86 | 269,83 | −359 953 | 5 779 215 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 131 | 22 752 | 10,33 | 8,67 | 18 469 | 197 185 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 203 | 20 621 | 0,99 | 10,40 | 2 111 | 214 460 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 20 418 | 8,63 | ||||
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 203 | −94,52 | |||
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 18 796 | −11,74 | 288,26 | −720 640 | 5 418 062 |
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 21 296 | −4,49 | 283,50 | −283 500 | 6 037 416 |
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 296 | 18,62 | 10,40 | 36 400 | 231 881 |
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 5 971 | −45,57 | |||
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 18 796 | −21,01 | 285,99 | −1 429 938 | 5 375 421 |
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 23 796 | 26,60 | 8,67 | 43 334 | 206 233 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 294 | 35 425 | −13,00 | |||
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 3 703 | −48,59 | |||
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 18 796 | −9,62 | 212,12 | −424 242 | 3 987 026 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 146 | 20 796 | −5,22 | 210,95 | −241 749 | 4 386 918 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 21 942 | −6,40 | 204,62 | −306 930 | 4 489 772 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 23 442 | 17,55 | 10,40 | 36 400 | 243 799 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 294 | 19 942 | 36,14 | 8,67 | 45 882 | 172 831 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 7 203 | −32,70 | |||
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 10 971 | −26,72 | |||
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −953 | 14 648 | −6,11 | 208,10 | −198 317 | 3 048 208 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 379 | 15 601 | −13,23 | 207,01 | −492 466 | 3 229 490 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 068 | 17 980 | −5,61 | 206,03 | −220 041 | 3 704 437 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 100 | 19 048 | −14,00 | 204,20 | −633 009 | 3 889 535 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 148 | 18,77 | 10,40 | 36 400 | 230 341 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 648 | 27,31 | 8,67 | 34 667 | 161 617 |
2015-01-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −664 | 14 648 | −4,34 | 172,63 | −114 627 | 2 528 702 |
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −376 | 15 312 | −2,40 | 158,71 | −59 675 | 2 430 169 |
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 6 490 | −20,00 | ||||
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 15 688 | 11,54 | ||||
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 10 703 | −27,21 | |||
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −502 | 14 065 | −3,45 | 160,30 | −80 471 | 2 254 622 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 698 | 14 567 | −10,44 | 159,62 | −271 038 | 2 325 214 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 590 | 16 265 | −8,91 | 158,45 | −251 939 | 2 577 225 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 855 | −5,30 | 157,28 | −157 282 | 2 808 279 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 855 | 26,93 | 10,40 | 41 600 | 196 094 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −832 | 14 855 | −5,30 | 233,97 | −194 664 | 3 475 639 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 14 703 | −21,39 | |||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 8 113 | −16,66 | ||||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 15 687 | −3,09 | 234,01 | −117 005 | 3 670 915 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 16 187 | −5,82 | 232,96 | −232 965 | 3 771 004 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 17 187 | −8,03 | 232,24 | −348 358 | 3 991 487 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −688 | 18 687 | −3,55 | 227,69 | −156 651 | 4 254 843 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 19 375 | −2,52 | 226,30 | −113 151 | 4 384 601 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 875 | 25,20 | 10,40 | 41 600 | 206 702 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 15 875 | 11,38 | ||||
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 000 | 18 703 | −17,62 | |||
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 14 253 | −6,56 | 286,75 | −286 750 | 4 087 048 |
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 15 253 | −16,44 | 279,33 | −838 001 | 4 260 678 |
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 253 | 28,06 | 10,40 | 41 600 | 189 833 |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −10 000 | 30 131 | −24,92 | ||||
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −700 | 14 253 | −4,68 | 296,14 | −207 295 | 4 220 832 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 200 | 14 953 | −7,43 | 295,61 | −354 732 | 4 420 255 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 250 | 16 153 | −20,83 | 293,89 | −1 249 025 | 4 747 178 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 850 | 20 403 | −15,87 | 293,05 | −1 128 233 | 5 979 048 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 24 253 | 70,16 | 8,67 | 86 667 | 210 193 | |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 000 | 22 703 | −14,98 | |||
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 14 253 | −21,91 | 292,16 | −1 168 656 | 4 164 215 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −774 | 18 253 | −4,07 | 288,00 | −222 912 | 5 256 864 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 027 | 26,62 | 10,40 | 41 600 | 197 883 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −849 | 15 027 | −5,35 | 247,65 | −210 257 | 3 721 477 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 26 703 | −13,03 | |||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 9 735 | −14,29 | ||||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 15 876 | −5,93 | 246,00 | −246 000 | 3 905 496 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 16 876 | −10,60 | 244,75 | −489 499 | 4 130 393 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 187 | 18 876 | −5,92 | 241,53 | −286 696 | 4 559 120 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 20 063 | 24,90 | 10,40 | 41 600 | 208 657 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 16 063 | 11,24 | ||||
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 30 703 | −11,53 | |||
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 160 | 14 440 | −13,01 | 279,62 | −603 976 | 4 037 688 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −840 | 16 600 | −4,82 | 278,55 | −233 982 | 4 623 930 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 440 | −5,42 | 274,63 | −274 630 | 4 789 547 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 440 | 27,70 | 10,40 | 41 600 | 191 778 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 34 703 | −10,34 | |||
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 14 440 | −6,48 | 278,10 | −278 104 | 4 015 815 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 15 440 | −11,47 | 277,00 | −554 000 | 4 276 880 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 440 | −5,42 | 275,00 | −275 000 | 4 796 000 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −743 | 18 440 | −3,87 | 272,00 | −202 096 | 5 015 680 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 183 | 26,35 | 10,40 | 41 600 | 199 505 |
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 8 255 | 8 255 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 1 835 | 1 835 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 1 504 | 15 183 | 10,99 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −879 | 13 679 | −6,04 | 321,95 | −282 997 | 4 403 994 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 326 | 0 | −100,00 | |||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 11 358 | −12,50 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 14 558 | −3,32 | 338,16 | −169 082 | 4 922 977 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 15 058 | −6,23 | 335,84 | −335 844 | 5 057 143 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −388 | 16 058 | −2,36 | 334,52 | −129 793 | 5 371 690 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 626 | 16 446 | −9,00 | 333,22 | −541 809 | 5 480 069 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 18 072 | −5,24 | 330,06 | −330 060 | 5 964 844 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 326 | 19 072 | 29,34 | 10,40 | 44 991 | 198 351 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 622 | 14 746 | 12,36 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to sell Common Stock |
M - Exercise | −4 000 | 38 703 | −9,37 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to sell Common Stock |
M - Exercise | −4 917 | 42 703 | −10,33 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 13 124 | −7,08 | 463,91 | −463 910 | 6 088 355 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 14 124 | −6,61 | 444,25 | −444 246 | 6 274 523 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 15 124 | −6,20 | 432,30 | −432 303 | 6 538 151 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −258 | 16 124 | −1,57 | 422,05 | −108 888 | 6 805 071 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −742 | 16 382 | −4,33 | 421,46 | −312 724 | 6 904 369 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −456 | 17 124 | −2,59 | 410,92 | −187 379 | 7 036 586 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 000 | 17 580 | 29,46 | 10,40 | 41 600 | 182 834 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 917 | 13 580 | 56,76 | 10,40 | 51 137 | 141 233 | |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 327 | 4 326 | −50,01 | |||
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 7 218 | −6,48 | 368,90 | −184 451 | 2 662 735 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 400 | 7 718 | −23,72 | 368,02 | −883 246 | 2 840 371 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 240 | 10 118 | −10,92 | 366,91 | −454 972 | 3 712 425 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 632 | 11 358 | −12,56 | 365,37 | −596 279 | 4 149 836 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 327 | 12 990 | 49,95 | 10,40 | 45 001 | 135 097 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 800 | 50 719 | −6,97 | |||
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −5 168 | 47 620 | −9,79 | |||
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −928 | 8 663 | −9,68 | 73,09 | −67 826 | 633 161 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 000 | 9 591 | −29,43 | 71,56 | −286 239 | 686 330 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 800 | 13 591 | 38,81 | 8,67 | 32 933 | 117 789 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 5 168 | 9 791 | 111,79 | 10,40 | 53 748 | 101 827 |
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 12 980 | −11,11 | ||||
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 623 | 4 623 | 54,10 | ||||
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 52 788 | −6,63 | |||
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −5 016 | 3 000 | −62,57 | 62,11 | −311 550 | 186 334 |
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 8 016 | 87,90 | 10,40 | 39 000 | 83 367 |
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 56 538 | −6,22 | |||
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 730 | 4 266 | −52,58 | 48,08 | −227 412 | 205 104 |
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 8 996 | 71,48 | 10,40 | 39 000 | 93 559 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −3 750 | 60 288 | −5,86 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −642 | 5 246 | −10,90 | 73,10 | −46 930 | 383 481 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −600 | 5 888 | −9,25 | 74,60 | −44 760 | 439 245 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 177 | 6 488 | −15,36 | 73,02 | −85 943 | 473 745 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 973 | 7 665 | −20,47 | 72,02 | −142 087 | 552 000 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 9 638 | 63,69 | 10,40 | 39 000 | 100 236 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 14 603 | −10,00 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 622 | 5 888 | 38,02 | ||||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 64 038 | −5,53 | |||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 9 282 | 67,79 | 10,40 | 39 000 | 96 534 |
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −5 016 | 4 266 | −54,04 | 49,20 | −246 784 | 209 884 |
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 67 788 | −5,24 | |||
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 754 | 2 532 | −65,25 | 45,04 | −214 120 | 114 041 |
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 7 286 | 106,05 | 10,40 | 39 000 | 75 775 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 71 538 | −4,98 | |||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 369 | 3 536 | −55,27 | 43,63 | −190 623 | 154 278 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 7 905 | 90,25 | 10,40 | 39 000 | 82 213 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 16 225 | −9,09 | ||||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 623 | 4 155 | 64,10 | ||||
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 75 288 | −4,74 | |||
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 2 532 | −21,66 | 32,75 | −22 925 | 82 923 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 316 | 3 232 | −50,64 | 32,75 | −108 599 | 105 848 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 6 548 | −13,25 | 32,60 | −32 600 | 213 465 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 7 548 | 98,74 | 10,40 | 39 000 | 78 500 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −496 | 79 038 | −0,62 | |||
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 798 | −2,57 | 31,30 | −3 130 | 118 877 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 898 | −2,50 | 31,26 | −3 126 | 121 851 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −662 | 3 998 | −14,21 | 31,22 | −20 668 | 124 818 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −435 | 4 660 | −8,54 | 31,22 | −13 581 | 145 485 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −465 | 5 095 | −8,36 | 31,20 | −14 508 | 158 964 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 496 | 5 560 | 9,79 | 10,40 | 5 158 | 57 825 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 254 | 79 534 | −3,93 | |||
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 064 | −1,94 | 31,74 | −3 174 | 160 731 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 5 164 | −5,49 | 31,70 | −9 509 | 163 675 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 464 | −1,80 | 31,58 | −3 158 | 172 553 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 564 | −1,77 | 31,56 | −3 156 | 175 600 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 5 664 | −3,41 | 31,54 | −6 308 | 178 643 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −80 | 5 864 | −1,35 | 31,50 | −2 520 | 184 716 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 | 5 944 | −0,17 | 31,46 | −315 | 186 998 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 954 | −1,65 | 31,40 | −3 140 | 186 950 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 6 054 | −1,62 | 31,39 | −3 139 | 190 035 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 6 154 | −1,60 | 31,37 | −3 137 | 193 051 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −838 | 6 254 | −11,82 | 31,35 | −26 271 | 196 063 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −120 | 7 092 | −1,66 | 31,29 | −3 754 | 221 885 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 | 7 212 | −0,14 | 31,27 | −313 | 225 519 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −90 | 7 222 | −1,23 | 31,23 | −2 811 | 225 531 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 7 312 | −2,66 | 31,19 | −6 238 | 228 061 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 7 512 | −1,31 | 31,14 | −3 114 | 233 924 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 7 612 | −6,16 | 31,13 | −15 565 | 236 962 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −90 | 8 112 | −1,10 | 31,12 | −2 801 | 252 475 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −20 | 8 202 | −0,24 | 31,11 | −622 | 255 164 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −30 | 8 222 | −0,36 | 30,99 | −930 | 254 800 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −50 | 8 252 | −0,60 | 30,98 | −1 549 | 255 647 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −16 | 8 302 | −0,19 | 30,70 | −491 | 254 871 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 254 | 8 318 | 64,26 | 10,40 | 33 842 | 86 508 |
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 22 500 | 22 500 | |||||
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
A - Award | 3 000 | 8 064 | 59,24 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −8 113 | 17 848 | −31,25 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
F - Taxes | −3 049 | 5 064 | −37,58 | 34,57 | −105 404 | 175 062 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 113 | 8 113 | |||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 100 | 0 | −100,00 | 34,50 | −72 450 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 100 | −4,55 | 34,38 | −3 438 | 72 198 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 2 200 | −8,33 | 34,38 | −6 875 | 75 625 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 2 400 | −7,69 | 34,35 | −6 870 | 82 440 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 600 | −3,70 | 34,33 | −3 433 | 89 250 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 700 | −3,57 | 34,32 | −3 432 | 92 664 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 2 800 | −9,68 | 34,31 | −10 293 | 96 068 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 3 100 | −8,82 | 34,30 | −10 290 | 106 330 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 400 | −2,86 | 34,29 | −3 429 | 116 586 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 3 500 | −5,41 | 34,25 | −6 850 | 119 875 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −50 | 3 700 | −1,33 | 33,86 | −1 693 | 125 282 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 3 750 | 10,40 | 39 000 | 39 000 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 82 788 | −4,33 | |||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 17 307 | 17 307 | |||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 25 961 | 25 961 |